cardene iv
Generic: nicardipine hydrochloride
Labeler: baxter healthcare corporationDrug Facts
Product Profile
Brand Name
cardene iv
Generic Name
nicardipine hydrochloride
Labeler
baxter healthcare corporation
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
nicardipine hydrochloride .2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
43066-016
Product ID
43066-016_af59ed9a-2f67-4aa6-8065-42cc661a4784
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA019734
Listing Expiration
2026-12-31
Marketing Start
1992-01-30
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
43066016
Hyphenated Format
43066-016
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cardene iv (source: ndc)
Generic Name
nicardipine hydrochloride (source: ndc)
Application Number
NDA019734 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .2 mg/mL
Packaging
- 10 BAG in 1 CARTON (43066-016-10) / 200 mL in 1 BAG
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "af59ed9a-2f67-4aa6-8065-42cc661a4784", "openfda": {"unii": ["K5BC5011K3"], "rxcui": ["858599", "858601", "858603", "858605"], "spl_set_id": ["f12cea0d-b7cd-41d8-b551-2c74cc7f5f4e"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BAG in 1 CARTON (43066-016-10) / 200 mL in 1 BAG", "package_ndc": "43066-016-10", "marketing_start_date": "20201026"}], "brand_name": "CARDENE IV", "product_id": "43066-016_af59ed9a-2f67-4aa6-8065-42cc661a4784", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "43066-016", "generic_name": "nicardipine hydrochloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CARDENE IV", "active_ingredients": [{"name": "NICARDIPINE HYDROCHLORIDE", "strength": ".2 mg/mL"}], "application_number": "NDA019734", "marketing_category": "NDA", "marketing_start_date": "19920130", "listing_expiration_date": "20261231"}